EUVIMEDEUVIMED entdecken
Crossref

Integrating network pharmacology, experimental validation and molecular docking to reveal the alleviation of Yinhuang granule on idiopathic pulmonary fibrosis

Zeqi Wu, Ruijia Shi, Shihao Yan, Shaobo Zhang, Bin Lu, Zhenlin Huang, Lili Ji

Phytomedicine · 2024-06 · 128 · 155368

DOI: 10.1016/j.phymed.2024.155368 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2024-06. Verfasst von Zeqi Wu und 6 weiteren Autor:innen. Beteiligte Einrichtung: The MOE Key Laboratory for Standardization of Chinese Medicines, Shanghai Key Laboratory of Compound Chinese Medicines and The SATCM Key Laboratory f…. Hauptthemen laut MEDLINE: Molecular Docking Simulation, Idiopathic Pulmonary Fibrosis, Drugs, Chinese Herbal, Bleomycin. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 53 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a chronic disease characterized by the abnormal proliferation of fibroblast and excessive deposition of extracellular matrix (ECM), accompanied by inflammation and ultimately respiratory failure. Yinhuang granule (YHG), with clinical properties of clearing heat, detoxifying and anti-inflammation, is commonly used to heal upper respiratory diseases in China for decades. PURPOSE: To explore the improvement of YHG on bleomycin (BLM)-induced IPF in mice and its possible engaged mechanism. METHODS: The mortality rate was recorded, lung function was determined and hematoxylin-eosin (H&E) staining was carried out to explore the alleviation of YHG on BLM-caused IPF in mice. Hydroxyproline, collagen I and collagen III contents were detected, and Sirius red and Masson staining were conducted to evaluate YHG's alleviation on lung fibrosis. The underlying mechanism was predicted by network pharmacology, and confirmed by Real-time polymerase chain reaction (RT-PCR), Western-blot (WB) and enzyme linked immunosorbent assay (ELISA). The binding affinity between related key proteins and active compounds in YHG was calculated by using molecular docking, and further validated by cellular thermal shift assay (CESTA). RESULTS: YHG (400, 800 mg/kg) weakened lung damage and pulmonary fibrosis in mice induced by BLM. Network pharmacology and experimental validation displayed that inflammation and angiogenesis participated in the YHG-provided improvement on IPF, and key involved molecules included tumor necrosis factor-α (TNFα), vascular endothelial growth factor-A (VEGFA), interleukine-6 (IL-6), etc. The data of molecular docking presented that some main active compounds from YHG had a high binding affinity with TNFR1 or VEGFR2, and some of them were further validated by CESTA. CONCLUSION: YHG effectively improved the BLM-induced IPF in mice via reducing inflammation and angiogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Molecular Docking SimulationIdiopathic Pulmonary FibrosisDrugs, Chinese HerbalBleomycinNetwork PharmacologyVascular Endothelial Growth Factor AAnimalsMiceMaleTumor Necrosis Factor-alphaHumansLungMice, Inbred C57BLDisease Models, Animal

Stichwörter der Autor:innen

IPFMolecular dockingNetwork pharmacologyYHG

Substanzen

Drugs, Chinese HerbalBleomycinVascular Endothelial Growth Factor ATumor Necrosis Factor-alpha

Autor:innen und Institutionen

  • The MOE Key Laboratory for Standardization of Chinese Medicines, Shanghai Key Laboratory of Compound Chinese Medicines and The SATCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicines, Institut…
  • School of Basic Medical Science of Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.

Zitieren

APA

Wu, Z., Shi, R., Yan, S., Zhang, S., Lu, B., Huang, Z., & Ji, L. (2024). Integrating network pharmacology, experimental validation and molecular docking to reveal the alleviation of Yinhuang granule on idiopathic pulmonary fibrosis. Phytomedicine, 128, 155368. https://doi.org/10.1016/j.phymed.2024.155368

Vancouver

Wu Z, Shi R, Yan S, Zhang S, Lu B, Huang Z, et al. Integrating network pharmacology, experimental validation and molecular docking to reveal the alleviation of Yinhuang granule on idiopathic pulmonary fibrosis. Phytomedicine. 2024;128:155368. doi:10.1016/j.phymed.2024.155368

BibTeX
@article{Wu2024,
  author = {Wu, Zeqi and Shi, Ruijia and Yan, Shihao and Zhang, Shaobo and Lu, Bin and Huang, Zhenlin and Ji, Lili},
  title = {Integrating network pharmacology, experimental validation and molecular docking to reveal the alleviation of Yinhuang granule on idiopathic pulmonary fibrosis},
  journal = {Phytomedicine},
  year = {2024},
  volume = {128},
  pages = {155368},
  doi = {10.1016/j.phymed.2024.155368}
}
Kostenlos starten →